Gut mycobiome alterations and implications for liver diseases
PLOS Pathogens · 2024
DOI: 10.1371/journal.ppat.1012377 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift PLOS Pathogens, 2024. Verfasst von Suling Zeng und 1 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Health and Medicine, Hefei Comprehensive National Science Center, Hefei, China. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Liver Diseases, Mycobiome, Dysbiosis. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC0). Gefördert von: NIAAA NIH HHS, BLRD VA, NIDDK NIH HHS.
Abstract (Originalsprache)
Chronic liver disease and its complications are a significant global health burden. Changes in fungal communities (mycobiome), an integral component of the gut microbiome, are associated with and contribute to the development of liver disease. Fungal dysbiosis can induce intestinal barrier dysfunction and allow fungal products to translocate to the liver causing progression of disease. This review explores recent progress in understanding the compositional and functional diversity of gut mycobiome signatures across different liver diseases. It delves into causative connections between gut fungi and liver diseases. We emphasize the significance of fungal translocation, with a particular focus on fungal-derived metabolites and immune cells induced by fungi, as key contributors to liver disease. Furthermore, we review the potential impact of the intrahepatic mycobiome on the progression of liver diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Institute of Health and Medicine, Hefei Comprehensive National Science Center, Hefei, China.
- Department of Medicine, University of California San Diego, La Jolla, California, United States of America.
- Department of Medicine, VA San Diego Healthcare System, San Diego, California, United States of America.
Förderung
- NIAAA NIH HHS
- BLRD VA
- NIDDK NIH HHS
- Foundation for the National Institutes of Health
- Biomedical Laboratory Research and Development, VA Office of Research and Development
- Hefei Comprehensive National Science Center
Zitieren
APA
Zeng, S., & Schnabl, B. (2024). Gut mycobiome alterations and implications for liver diseases. PLOS Pathogens. https://doi.org/10.1371/journal.ppat.1012377
Vancouver
Zeng S, Schnabl B. Gut mycobiome alterations and implications for liver diseases. PLOS Pathogens. 2024. doi:10.1371/journal.ppat.1012377
BibTeX
@article{Zeng2024,
author = {Zeng, Suling and Schnabl, Bernd},
title = {Gut mycobiome alterations and implications for liver diseases},
journal = {PLOS Pathogens},
year = {2024},
doi = {10.1371/journal.ppat.1012377}
}
EUVIMED